NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/18/2026 14:02
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization875.11 mln
Float32.17 mln
Earnings Date11/05/2026
EPS
1.27
Moderate
P / E
22.21
Premium valuation
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-3.22
Reliable
1-Year Forecast
51.20
Transformational upside
Relative Strength
5
/ 100
Severely lagging
Business Description
Collegium Pharmaceutical is a Massachusetts-based company focused on bringing pain management treatments to patients. Its product lineup includes several prescription medicines that address conditions ranging from severe chronic pain and ADHD to opioid-induced constipation. Founded in 2002, the company has built a portfolio of both extended-release and immediate-release formulations designed to give doctors and patients more tailored treatment options.
